Pharma Marketing Network

"I was also wrong about disclosure," said James Stein, MD at a University of Wisconsin conflict of interest seminar (see video here). Dr. Stein,...

While Kevin Nalty worked during the day as Con-sumer Product Director at Merck, where he marketed Propecia, at night and on weekends he was making comedic videos for YouTube -- a few of which were critical of drug ads, marketing, and medical conditions. Read this interesting story and learn how not to get fired doing new media marketing.

At a recent ExL Pharma conference industry leaders from pharma and the vendor community reviewed the impact on

Arnold Friede, counsel to the law firm McDermott Will & Emery LLP, and former Senior Counsel at Pfizer, believes that there is an opportunity now to make a strong and compelling argument for the adoption of rational regulatory policies by the FDA that address the unique features not only of sponsored links, but of other kinds of new communication tools, such as social media.

In response to concerns about the growing range of threats to brand value and the sheer volume of brand hijacking incidents, the CMO Council set out to assess the challenges marketers face as stewards of their brands. The result is Protection from Brand Infection, a seminal authority leadership report that outlines the proliferating threat-scape that marketers face and reveals how marketers are struggling to understand and measure the impact brand intrusions have on their second most valuable asset, their customer.

Welcome to the May 2009 issue of Pharma Marketing News.

There’s nothing like a little FDA letter writing campaign to stir the pot! Yes, I’m talking about the 14 letters FDA sent out on...

Sung to the tune “50 Ways to Leave Your Lover” by Paul Simon"The problem is all inside your head", FDA said to meThe answer...

This week, the world is all a-Twitter about the outbreak of Swine Flu. Two stories caught my attention:FDA Authorizes Emergency Use of Influenza Medicines,...